Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IN 114199

Next Previous
Drug Profile

IN 114199

Alternative Names: CJ-14199; IN-114199

Latest Information Update: 26 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CJ Cheiljedang Corp.
  • Developer HK inno.N
  • Class Hepatoprotectants; Irritable bowel syndrome therapies
  • Mechanism of Action Sodium-bile acid cotransporter inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Constipation
  • Discontinued Irritable bowel syndrome; Non-alcoholic steatohepatitis

Most Recent Events

  • 19 Dec 2024 Discontinued - Phase-I for Non-alcoholic steatohepatitis in South Korea (PO) (HK inno.N pipeline, December 2024)
  • 19 Dec 2024 Discontinued - Preclinical for Irritable bowel syndrome in South Korea (PO) (HK inno.N pipeline, December 2024)
  • 16 Dec 2024 Phase-I clinical trials in Constipation (In volunteers) in South Korea (PO) (NCT06736912) (HK inno.N pipeline, December 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top